ES2188580T3 - Sistema para uso en un metodo de tratamiento terapeutico o de diagnostico. - Google Patents

Sistema para uso en un metodo de tratamiento terapeutico o de diagnostico.

Info

Publication number
ES2188580T3
ES2188580T3 ES90914303T ES90914303T ES2188580T3 ES 2188580 T3 ES2188580 T3 ES 2188580T3 ES 90914303 T ES90914303 T ES 90914303T ES 90914303 T ES90914303 T ES 90914303T ES 2188580 T3 ES2188580 T3 ES 2188580T3
Authority
ES
Spain
Prior art keywords
medical agent
therapeutic
diagnostic treatment
treatment method
normal clearance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90914303T
Other languages
English (en)
Inventor
Stephen W Maddock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitra Medical Technology AB
Original Assignee
Mitra Medical Technology AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitra Medical Technology AB filed Critical Mitra Medical Technology AB
Application granted granted Critical
Publication of ES2188580T3 publication Critical patent/ES2188580T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrotherapy Devices (AREA)

Abstract

ES UN METODO DE TRATAMIENTO TERAPEUTICO O DIAGNOSTICO USANDO UN AGENTE MEDICO, EN EL CUAL HABRA EFECTOS BENEFICIOSOS SI EL NIVEL DE CIRCULACION DE DICHO AGENTE SE REDUCE ARTIFICIALMENTE MAS RAPIDAMENTE, QUE MEDIANTE LA REDUCCION POR EL ACLARAMIENTO NORMAL O POR VIAS QUE EVITEN LOS MECANISMOS NORMALES DE ACLARAMIENTO. EL METODO INCLUYE LA EXTRACCION EXTRACORPOREA DEL AGENTE MEDICO PASANDO EL LIQUIDO CORPORAL DEL PACIENTE POR UN SOPORTE ADAPTADO PARA EXTRAER SELECTIVAMENTE EL AGENTE MEDICO.-
ES90914303T 1989-08-02 1990-08-02 Sistema para uso en un metodo de tratamiento terapeutico o de diagnostico. Expired - Lifetime ES2188580T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38866489A 1989-08-02 1989-08-02

Publications (1)

Publication Number Publication Date
ES2188580T3 true ES2188580T3 (es) 2003-07-01

Family

ID=23535010

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90914303T Expired - Lifetime ES2188580T3 (es) 1989-08-02 1990-08-02 Sistema para uso en un metodo de tratamiento terapeutico o de diagnostico.

Country Status (6)

Country Link
US (2) US5474772A (es)
EP (1) EP1327454A3 (es)
AT (1) ATE233100T1 (es)
DE (1) DE69034042T2 (es)
DK (1) DK0436717T3 (es)
ES (1) ES2188580T3 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100142L (sv) 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal
US5753227A (en) * 1993-07-23 1998-05-19 Strahilevitz; Meir Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
US7166295B1 (en) 1995-05-26 2007-01-23 Meir Strahilevitz Methods of treatment and diagnostic visualization, particularly in cancer
US20010023288A1 (en) * 1999-07-07 2001-09-20 Wilbur D. Scott Trifunctional reagent for conjugation to a biomolecule
WO2000002050A1 (en) * 1998-07-07 2000-01-13 Department Of Radiation Oncology, University Of Washington Trifunctional reagent for conjugation to a biomolecule
US7011812B1 (en) 1996-05-03 2006-03-14 Immunomedics, Inc. Targeted combination immunotherapy of cancer and infectious diseases
WO1997041898A1 (en) * 1996-05-03 1997-11-13 Immunomedics, Inc. Targeted combination immunotherapy of cancer
US5817770A (en) 1997-03-21 1998-10-06 Drug Abuse Sciences, Inc. Cocaethylene immunogens and antibodies
ATE368477T1 (de) * 2000-06-20 2007-08-15 Immunomedics Inc Zielgerichtete kombinationsimmuntherapie für krebs und infektionskrankheiten
WO2002030474A1 (en) * 2000-10-12 2002-04-18 Mitra Medical Technology Ab Kit for intraperitoneal administration and extracorpeal removal of a drug
AU2003290506A1 (en) * 2002-04-02 2004-04-30 Scantibodies Laboratory, Inc. Methods and devices for treating severe peripheral bacterial infections
WO2003090781A1 (en) * 2002-04-23 2003-11-06 Meir Strahilevitz Methods and devices for targeting a site in a mammal and for removing species from a mammal
WO2006017763A2 (en) * 2004-08-04 2006-02-16 Aspira Biosystems, Inc. Capture and removal of biomolecules from body fluids using partial molecular imprints
CN102512187B (zh) 2004-11-16 2015-08-12 拜耳医疗保健公司 对病人体内的药物传播建模的系统和方法
US7925330B2 (en) 2004-11-24 2011-04-12 Medrad, Inc. Devices, systems and methods for determining parameters of one or more phases of an injection procedure
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
WO2008085421A2 (en) 2006-12-29 2008-07-17 Medrad, Inc. Patient-based parameter generation systems for medical injection procedures
US8428694B2 (en) 2007-07-17 2013-04-23 Medrad, Inc. Methods for determination of parameters for a procedure, for estimation of cardiopulmonary function and for fluid delivery
US8165663B2 (en) * 2007-10-03 2012-04-24 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation
US8285366B2 (en) 2007-10-04 2012-10-09 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation associated with a local bypass
US8285367B2 (en) * 2007-10-05 2012-10-09 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation associated with a reservoir
US9421330B2 (en) 2008-11-03 2016-08-23 Bayer Healthcare Llc Mitigation of contrast-induced nephropathy
US8317737B2 (en) 2009-02-25 2012-11-27 The Invention Science Fund I, Llc Device for actively removing a target component from blood or lymph of a vertebrate subject
US8758330B2 (en) 2010-03-05 2014-06-24 The Invention Science Fund I, Llc Device for actively removing a target cell from blood or lymph of a vertebrate subject
US8167871B2 (en) * 2009-02-25 2012-05-01 The Invention Science Fund I, Llc Device for actively removing a target cell from blood or lymph of a vertebrate subject
US8430831B2 (en) * 2009-02-25 2013-04-30 The Invention Science Fund I, Llc Device, system, and method for controllably reducing inflammatory mediators in a subject
US20110295175A1 (en) * 2010-03-16 2011-12-01 Marv Enterprises Llc Sequential Extracoporeal Treatment of Bodily Fluids
BR112012033116A2 (pt) 2010-06-24 2016-10-25 Medrad Inc modelagem da propagação de fármaco e geração de parâmetro para protocolos de injeção
CA2873351C (en) 2012-05-14 2022-07-26 Bayer Medical Care Inc. Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage
US9555379B2 (en) 2013-03-13 2017-01-31 Bayer Healthcare Llc Fluid path set with turbulent mixing chamber, backflow compensator
WO2017152036A1 (en) 2016-03-03 2017-09-08 Bayer Healthcare Llc System and method for improved fluid delivery in multi-fluid injector systems
WO2018087720A1 (en) 2016-11-14 2018-05-17 Novartis Ag Compositions, methods, and therapeutic uses related to fusogenic protein minion
CA3067740A1 (en) 2017-08-31 2019-03-07 Bayer Healthcare Llc Method for drive member position and fluid injection system mechanical calibration
AU2018323442B2 (en) 2017-08-31 2024-06-27 Bayer Healthcare Llc Fluid path impedance assessment for improving fluid delivery performance
AU2018326386B2 (en) 2017-08-31 2024-03-28 Bayer Healthcare Llc Fluid injector system volume compensation system and method
EP3675931B1 (en) 2017-08-31 2021-08-11 Bayer Healthcare LLC Injector pressure calibration system and method
JP7493337B2 (ja) 2017-08-31 2024-05-31 バイエル・ヘルスケア・エルエルシー 流体インジェクタシステムにおける動的圧力制御のための方法
GB201717555D0 (en) * 2017-10-25 2017-12-06 Nonwovens Innovation & Res Institute Ltd Blood filter

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375414A (en) * 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate
US4223672A (en) * 1979-02-08 1980-09-23 Baxter Travenol Laboratories, Inc. Variable volume plasma treatment chamber for an apparatus for the extracorporeal treatment of disease
US4215688A (en) * 1979-02-09 1980-08-05 Baxter Travenol Laboratories, Inc. Apparatus for the extracorporeal treatment of disease
US4350156A (en) * 1980-05-29 1982-09-21 Japan Foundation For Artificial Organs Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
US4824432A (en) * 1981-03-24 1989-04-25 S.V.S. Laboratories, Inc. Method for treating AIDS and other immune deficiencies and immune disorders
US4687808A (en) * 1982-08-12 1987-08-18 Biospecific Technologies, Inc. Activation of biocompatible polymers with biologicals whose binding complements are pathological effectors
CA1221307A (en) * 1982-12-02 1987-05-05 Nobutaka Tani Adsorbent and process for preparing the same
CA1236738A (en) * 1983-06-01 1988-05-17 Mark R. Honard Therapeutic device
US4551435A (en) * 1983-08-24 1985-11-05 Immunicon, Inc. Selective removal of immunospecifically recognizable substances from solution
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
US4863713A (en) * 1986-06-23 1989-09-05 The Board Of Trustees Of Leland Stanford Jr. Univ. Method and system for administering therapeutic and diagnostic agents
US4877599A (en) * 1986-11-10 1989-10-31 New England Deaconess Hospital Corporation Detection of vascular disease with labelled antibodies
US5122112A (en) * 1986-11-21 1992-06-16 Imre Corporation Antigen-specific removal of circulating immune complexes
US4800016A (en) * 1986-11-24 1989-01-24 The University Of Michigan Extracorporeal blood de-heparinization system
DE3705637A1 (de) * 1987-02-21 1988-09-29 Bissendorf Peptide Gmbh Vorrichtung zur entfernung von lokal applizierten wirkstoffen gegen solide tumoren
US4846786A (en) * 1987-04-30 1989-07-11 Massachusetts Institute Of Technology Bioreactor containing suspended, immobilized species
US4885207A (en) * 1987-07-13 1989-12-05 Uop Biocompatible protein or ligand immobilization system
US4865841A (en) * 1987-10-23 1989-09-12 Imre Corporation Methods and compositions for transient elimination of humoral immune antibodies
US5069662A (en) * 1988-10-21 1991-12-03 Delcath Systems, Inc. Cancer treatment
US5149425A (en) * 1988-11-09 1992-09-22 Chembiomed, Ltd. Affinity supports for hemoperfusion
CA2025899A1 (en) * 1989-01-23 1990-07-24 Reinhard Bredehorst Site specific in-vivo activation of therapeutic drugs
US5252466A (en) * 1989-05-19 1993-10-12 Biotechnology Research And Development Corporation Fusion proteins having a site for in vivo post-translation modification and methods of making and purifying them
JP2922641B2 (ja) * 1989-08-02 1999-07-26 コーベ ラボラトリーズ，インコーポレーテッド 医学的薬剤による治療法
SE9100142L (sv) * 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal

Also Published As

Publication number Publication date
DE69034042D1 (de) 2003-04-03
DE69034042T2 (de) 2003-07-17
EP1327454A2 (en) 2003-07-16
US6046225A (en) 2000-04-04
DK0436717T3 (da) 2003-05-05
US5474772A (en) 1995-12-12
EP1327454A3 (en) 2003-12-03
ATE233100T1 (de) 2003-03-15

Similar Documents

Publication Publication Date Title
ES2188580T3 (es) Sistema para uso en un metodo de tratamiento terapeutico o de diagnostico.
BR8203384A (pt) Sistema para tratamento do sangue de um paciente
SE9100142D0 (sv) A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose
ATE63826T1 (de) Pumpenkoerper zum anschluss einer bestrahlungskammer an ein system zur behandlung eines patienten durch photoaktivierung.
PT93791A (pt) Dispositivo para tratamento de residuos medicos especiais
FR2703254B1 (fr) Dispositif de traitement thérapeutique d'un tissu pathologique, comportant un cathéter .
NO905437L (no) Kateteranordning for hindring av blodlekkasje.
DE3771100D1 (de) Einwegtemperaturfuehler fuer ein system zur behandlung eines patienten durch photoaktivierung.
DE58908452D1 (de) Medizinisches Gerät zur Diagnose und/oder Therapie.
DE3767196D1 (de) Ventileinrichtung fuer ein system zur behandlung eines patienten durch photoaktivierung.
NO175023C (no) Fremgangmåte for in vitro diagnostisering av en innflammasjonssykdom indusert av immunkomplekser som er i omlöp, og fremgangsmåte for fremstilling av dsRNA til den in vitro diagnostisering
Stone et al. Mobilization of Radioactive Sodium from the Gastrocnemius Muscle of the Dog.
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
BR8905985A (pt) Composicao liquida aquosa para tratamento de tecidos
CA2037933A1 (en) Method of Treatment with Medical Agents
MX155537A (es) Sistema terapeutico para tratamiento extracorporal
GB2108400A (en) Method and apparatus for treating blood and the like
IT7822027A0 (it) Apparecchio medicale per la cura della trombosi venale profonda.
ES2031846T3 (es) Compuesto medico que contiene tpa y uso del mismo.
FR2637582B1 (fr) Systeme de traitement de l'eau par synergie de la reactivation avec la cavitation
IT8148480A0 (it) Composizione terapeutica e sistema per il trattamento extracorporeo di sangue intero
IT8247890A0 (it) Apparecchio per il trattamento chirurgico delle ossa e delle giunture
SU826588A1 (ru) Способ консервативного лечени неврологических синдромов при шейном остеохондрозе
ES556906A0 (es) Sistema de control de la temperatura de la sangre de un paciente en cirujia cardiaca
SE8603746D0 (sv) System for extracorporeal blodbehandling